Dysphagia Knowledge Hub — 吞嚥困難知識庫

Transitioning Between IDDSI Levels: Clinical Criteria, Trial Food Protocol, Documentation, and Family Education

Why Level Transitions Require a Structured Approach

IDDSI texture and liquid levels are clinical prescriptions, not general guidelines. A transition between levels — whether upgrading toward a less restricted diet or downgrading in response to deterioration — carries the same clinical weight as a medication change. It alters the patient’s aspiration risk profile, nutritional access, and quality of life. Unstructured transitions driven by caregiver convenience, patient preference without assessment, or administrative assumption represent a significant proportion of preventable aspiration events in both inpatient and community settings.

A structured transition approach provides three clinical guarantees: the change is based on objective criteria rather than subjective impression; the patient’s safety is verified at the new level before it becomes the standing prescription; and all parties — clinical team, caregiver, family, and patient — share a consistent understanding of what the change means and what to watch for.

Criteria for Upgrading IDDSI Level

Upgrade from a more to a less restricted level (e.g., Level 4 to Level 5, or Level 5 to Level 6) should be considered when the following criteria are met:

Clinical improvement is documented. The patient’s underlying condition — stroke, neurological disease, surgical recovery, or critical illness — shows measurable improvement. Speech-language pathology re-assessment confirms improved tongue strength, improved pharyngeal timing, reduced residue on instrumental assessment, or reduced aspiration frequency.

No active respiratory compromise. Active chest infection, fever, unexplained drop in oxygen saturation, or recent diagnosis of aspiration pneumonia should pause any upgrade consideration until the acute event is resolved and re-assessed.

The patient is medically stable. Any change in level should occur during a period of medical stability, not during an acute deterioration or immediately after initiation of a new medication with potential neurological effects.

The patient and family are informed and in agreement. Upgrades should not occur without the patient’s knowledge. Informed consent to trial a new level, including understanding of the associated risks, is part of ethically sound clinical practice.

Criteria for Downgrading IDDSI Level

Downgrade from a less to a more restricted level (e.g., Level 6 to Level 5, or Level 7 to Level 6) should be initiated when:

Clinical signs of aspiration emerge or worsen. New or increased wet vocal quality after meals, new-onset coughing or throat clearing during or after eating, unexplained fever, weight loss despite adequate meal provision, or recurrent lower respiratory tract infections all warrant urgent clinical review and likely downgrade pending re-assessment.

Fatigue or behavioural changes affect swallowing safety. Increased meal duration, progressive avoidance of specific textures, reports from caregivers of distress during meals, or meal-end deterioration that was not present at assessment suggest the current level may no longer be safe across full meal conditions.

Underlying condition progresses. Patients with progressive neurological conditions require proactive downgrade planning, not reactive response to aspiration events. Scheduled re-evaluation every 3–6 months is the minimum for patients with motor neuron disease, progressive bulbar palsy, Parkinson’s disease with dysphagia, or progressive dementia.

Step-by-Step Trial Food Protocol

When clinical criteria support an upgrade, the following protocol guides a structured trial:

Step 1 — Identify the target level. Specify the exact IDDSI level being trialled. Do not trial across two levels simultaneously. Document the current level, target level, and rationale.

Step 2 — Select appropriate trial foods. Choose 2–3 foods that clearly represent the target level and have been verified by the appropriate IDDSI test (fork pressure, knife cut, spoon tilt, or syringe flow). Select foods the patient is motivated to eat — engagement improves observation quality.

Step 3 — Conduct the trial meal under clinical observation. An SLP or trained clinician should be present for the first 1–2 trial meals. Observe throughout the entire meal, not only the initial portion — fatigue-related deterioration may appear late. Document: rate of oral processing, presence of coughing or throat clearing, voice quality before and after, meal completion rate, and any subjective reports from the patient.

Step 4 — Review after trial period. A standard trial period is 3–5 supervised meals before formalising the new level prescription. If the patient completes the trial without clinical signs of difficulty, the new level becomes the standing prescription. If any adverse signs emerge, pause the trial, revert to the prior level, and arrange instrumental assessment.

Step 5 — Communicate the change. Update the patient’s diet order, bedside signage, meal tray card, nursing documentation, and medication administration record (if liquid levels are involved). Notify the dietitian for nutritional reassessment.

Documentation Standards

Every IDDSI level transition — upgrade or downgrade — should generate a clinical record entry that includes:

Avoid vague documentation such as “diet upgraded as patient improving” without specifying levels. Transitions documented only in nursing notes without SLP record, or communicated verbally without written record, are common sources of handover failure — particularly at discharge from hospital to community or residential care.

Family Education

Family members and informal caregivers are often responsible for implementing IDDSI texture prescriptions at home. They are also the first observers of mealtime deterioration and the most likely agents of intentional or unintentional non-compliance with texture restriction.

Effective family education at the point of level transition should address:

What the new level means in practical terms. Do not rely solely on IDDSI level names or numbers. Show the caregiver what Level 6 food looks and feels like. Demonstrate the knife cut test. Explain which specific foods are now permitted or excluded.

What signs should prompt contact with the clinical team. Write down the warning signs — coughing during meals, wet voice, food refusal, weight loss — and provide a contact number. Families who know what to look for are far more likely to report early deterioration than those given only instructions about food preparation.

Why the prescription matters. Families may perceive texture restriction as unnecessarily cautious, particularly when the patient appears to eat well or expresses frustration with modified food. Explaining the mechanism of aspiration — including the phenomenon of silent aspiration — in accessible language significantly improves adherence. Patients and families who understand that aspiration can occur without any coughing are more likely to maintain prescribed restrictions than those who believe visible distress is the only marker of unsafe swallowing.

What to do if the patient refuses the prescribed texture. Food refusal at a modified texture level is common and represents a genuine ethical dilemma between autonomy and safety. Establish a clear plan with the clinical team in advance: document the patient’s informed refusal, agree on a monitoring protocol, and review at defined intervals. Do not leave caregivers to manage this situation alone without clinical guidance.

Transitions at Discharge

Care transitions — hospital to home, hospital to residential care, residential care to acute hospital — are high-risk periods for IDDSI prescription errors. The receiving setting may use different terminology, unfamiliar equipment, or different food service systems. Discharge documentation should:

Where possible, a direct handover call between the discharging SLP and the receiving care team is the most reliable way to ensure prescription continuity.

Summary

IDDSI level transitions — whether upgrades or downgrades — should be based on explicit clinical criteria, conducted through a structured trial food protocol, documented with full clinical detail, and communicated clearly to families and caregivers. Upgrade criteria include documented clinical improvement, medical stability, and absence of respiratory compromise. Downgrade criteria include emerging aspiration signs, fatigue-related deterioration, and disease progression. A standard trial involves 3–5 supervised meals using verified target-level foods before formalising the new prescription. Family education should cover practical food preparation, warning signs, rationale for restriction, and the plan for refusal. Special attention to documentation and handover communication is required at all care transitions.